Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
暂无分享,去创建一个
[1] E. Ling,et al. Insulin-like growth factor I and II expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid , 2006, Neuroscience.
[2] D. Ingram,et al. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. , 2006, Human molecular genetics.
[3] S. Waxman,et al. Activated Microglia Contribute to the Maintenance of Chronic Pain after Spinal Cord Injury , 2006, The Journal of Neuroscience.
[4] R. Khokha,et al. TIMP-3 deficiency in the host, but not in the tumor, enhances tumor growth and angiogenesis , 2006, Oncogene.
[5] R. Barbucci,et al. Differential selectivity of hyaluronidase inhibitors toward acidic and basic hyaluronidases. , 2006, Glycobiology.
[6] Robert D. Cardiff,et al. Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.
[7] D. Gutmann,et al. Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation , 2005, Development.
[8] N. Warrington,et al. Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies. , 2005, Cancer research.
[9] T. Postolache,,et al. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge , 2005, Neurological research.
[10] M. Fehlings,et al. Disruption of the hyaluronan‐based extracellular matrix in spinal cord promotes astrocyte proliferation , 2005, Glia.
[11] W. Streit,et al. Role of microglia in the central nervous system's immune response , 2005, Neurological research.
[12] C. Lewis,et al. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.
[13] Nico van Rooijen,et al. Microglia Stimulate the Invasiveness of Glioma Cells by Increasing the Activity of Metalloprotease-2 , 2005, Journal of neuropathology and experimental neurology.
[14] Erik Sahai,et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.
[15] D. Gutmann,et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. , 2005, Cancer research.
[16] D. Gutmann,et al. Natural history of neurofibromatosis 1–associated optic nerve glioma in mice , 2005, Annals of neurology.
[17] D. Gutmann,et al. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. , 2005, Cancer research.
[18] H. Moses,et al. Stromal fibroblasts in cancer initiation and progression , 2004, Nature.
[19] Rameen Beroukhim,et al. Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.
[20] A. Aguzzi,et al. IL-6 is required for glioma development in a mouse model , 2004, Oncogene.
[21] J. Epstein,et al. Tie2-Cre–Induced Inactivation of a Conditional Mutant Nf1 Allele in Mouse Results in a Myeloproliferative Disorder that Models Juvenile Myelomonocytic Leukemia , 2004, Pediatric Research.
[22] K. North,et al. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. , 2004, Ophthalmology.
[23] S. Ledbetter,et al. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism , 2004, Cancer Chemotherapy and Pharmacology.
[24] D. Viskochil. It takes two to tango: mast cell and Schwann cell interactions in neurofibromas. , 2003, The Journal of clinical investigation.
[25] D. Gutmann,et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. , 2003, Cancer research.
[26] J. Serratosa,et al. High‐yield isolation of murine microglia by mild trypsinization , 2003, Glia.
[27] W. Birchmeier,et al. Met, metastasis, motility and more , 2003, Nature Reviews Molecular Cell Biology.
[28] L. Coussens,et al. The tumor microenvironment: a critical determinant of neoplastic evolution. , 2003, European journal of cell biology.
[29] Andrew L Kung,et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] A. King,et al. Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome , 2003, American journal of medical genetics. Part A.
[31] D. Gutmann,et al. The Neurofibromatosis 1 Gene Product Neurofibromin Regulates Pituitary Adenylate Cyclase-Activating Polypeptide-Mediated Signaling in Astrocytes , 2003, The Journal of Neuroscience.
[32] Alexandra Kretz,et al. Monocyte chemoattractant protein–1 increases microglial infiltration and aggressiveness of gliomas , 2003, Annals of neurology.
[33] T. Jacks,et al. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor. , 2003, Genes & development.
[34] D. Gutmann,et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). , 2002, Neurology.
[35] D. Gutmann,et al. Astrocyte-Specific Inactivation of the Neurofibromatosis 1 Gene (NF1) Is Insufficient for Astrocytoma Formation , 2002, Molecular and Cellular Biology.
[36] S. Stylli,et al. Overexpression of Hyaluronan Synthase-2 Reduces the Tumorigenic Potential of Glioma Cells Lacking Hyaluronidase Activity , 2002, Neurosurgery.
[37] D. Burns,et al. Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment , 2002, Science.
[38] Dong-Kug Choi,et al. Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.
[39] G. Reifenberger,et al. The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.
[40] G. Tarozzo,et al. Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain , 2002, Stroke.
[41] Werner Paulus,et al. Microglia promote glioma migration , 2002, Acta Neuropathologica.
[42] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[43] B. Fiebich,et al. Minocycline, a Tetracycline Derivative, Is Neuroprotective against Excitotoxicity by Inhibiting Activation and Proliferation of Microglia , 2001, The Journal of Neuroscience.
[44] G. Reichmann,et al. Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation1 , 2001, The Journal of Immunology.
[45] W. Roggendorf,et al. Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study , 2001, Acta Neuropathologica.
[46] D. Gutmann,et al. Loss of Neurofibromin Is Associated with Activation of RAS/MAPK and PI3‐K/AKT Signaling in a Neurofibromatosis 1 Astrocytoma , 2000, Journal of neuropathology and experimental neurology.
[47] D. Gutmann,et al. Loss of neurofibromatosis 1 (NF1) gene expression in NF1‐associated pilocytic astrocytomas , 2000, Neuropathology and applied neurobiology.
[48] B. Badie,et al. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. , 2000, Neurosurgery.
[49] P. Chan,et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] T. Jacks,et al. In vitro and in vivo effects of a farnesyltransferase inhibitor on Nf1-deficient hematopoietic cells. , 1999, Blood.
[51] A. I. Yudin,et al. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. , 1999, Cancer research.
[52] B. Badie,et al. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. , 1999, Neurosurgery.
[53] J. Friedman. Epidemiology of neurofibromatosis type 1. , 1999, American journal of medical genetics.
[54] B. R. Korf,et al. Plexiform neurofibromas. , 1999, American journal of medical genetics.
[55] L. Gold. The role for transforming growth factor-beta (TGF-beta) in human cancer. , 1999, Critical reviews in oncogenesis.
[56] T. Hökfelt,et al. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] T. Jacks,et al. Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines , 1998, The Journal of experimental medicine.
[58] N. Block,et al. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. , 1997, Cancer research.
[59] D. Louis,et al. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task force , 1997 .
[60] W. Paulus,et al. Distribution and characterization of microglia/macrophages in human brain tumors , 1996, Acta Neuropathologica.
[61] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[62] J. Charrow,et al. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. , 1995, The Journal of pediatrics.
[63] R. Bjerkvig,et al. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen‐presenting cells , 1994, Journal of leukocyte biology.
[64] Jack Antel,et al. Phenotypic Differences between Human Monocytes/Macrophages and Microglial Cells Studied In Situ and In Vitro , 1994, Journal of neuropathology and experimental neurology.
[65] J. Charrow,et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. , 1994, The Journal of pediatrics.
[66] A. Harris,et al. Secretion of epidermal growth factor by macrophages associated with breast carcinoma , 1993, The Lancet.
[67] V. Perry,et al. Macrophages and inflammation in the central nervous system , 1993, Trends in Neurosciences.
[68] A. Bar-Or,et al. Biology of Adult Human Microglia in Culture: Comparisons with Peripheral Blood Monocytes and Astrocytes , 1992, Journal of neuropathology and experimental neurology.
[69] E. Thiel,et al. Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expressing c-kit protooncogene. , 1992, Cancer research.
[70] R. Tamargo,et al. Angiogenesis inhibition by minocycline. , 1991, Cancer research.
[71] H. Moses,et al. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. , 1984, Science.